Istituto di Cardiologia, Policlinico S. Orsola, Università di Bologna, Bologna, Italy.
Am J Cardiol. 2010 Mar 1;105(5):605-10. doi: 10.1016/j.amjcard.2009.10.037. Epub 2010 Jan 22.
Scant data are available on the relation between ST-segment elevation (STE) resolution and 30-day mortality in patients with STE acute myocardial infarction treated with percutaneous coronary intervention in contemporary, real world, clinical practice. Furthermore, whether the prognostic value of STE resolution is influenced by the patient clinical risk profile or postprocedural Thrombolysis In Myocardial Infarction (TIMI) flow has never been investigated. Lombardima was an observational registry implemented in Lombardy, a Northern Italian region. The clinical characteristics, electorcardiographic parameters, and procedural data were prospectively entered into a Web-based database. In the present study, we enrolled 3,403 patients. STE resolution occurred in 2,452 patients (group 1) and did not in 951 patients (group 2). The mortality rate was 2.4% in group 1 and 11.3% in group 2 (p <0.001). After stratifying patients according to their TIMI risk index, we observed that STE resolution was an independent predictor of 30-day mortality across all spectrum of clinical risk. Furthermore, in patients with TIMI 3 flow, STE resolution remained an independent predictor of 30-day mortality (p <0.0001). In conclusion, STE resolution was a strong and independent predictor of 30-day mortality in patients with STE acute myocardial infarction undergoing percutaneous coronary intervention across all spectrum of clinical risk.
关于经皮冠状动脉介入治疗 ST 段抬高急性心肌梗死患者 ST 段回落与 30 天死亡率之间的关系,目前仅有少量数据。此外,ST 段回落的预后价值是否受患者临床风险特征或经皮冠状动脉介入治疗后血流的影响,尚未进行研究。Lombardima 观察性注册研究在意大利北部伦巴第地区开展。临床特征、心电图参数和手术数据前瞻性地输入到一个基于网络的数据库中。本研究共纳入 3403 例患者。2452 例(第 1 组)患者出现 ST 段回落,951 例(第 2 组)患者未出现 ST 段回落。第 1 组患者的死亡率为 2.4%,第 2 组为 11.3%(p<0.001)。根据 TIMI 风险指数对患者进行分层后,我们发现 ST 段回落是所有临床风险谱中 30 天死亡率的独立预测因子。此外,在 TIMI 血流 3 级的患者中,ST 段回落仍然是 30 天死亡率的独立预测因子(p<0.0001)。总之,ST 段回落是经皮冠状动脉介入治疗 ST 段抬高急性心肌梗死患者 30 天死亡率的一个强而独立的预测因子,在所有临床风险谱中均如此。